AD-MSC (Adipose-Derived Mesenchymal Stem Cells)

adipose-derived mesenchymal stem cells · Mayo Clinic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-MSC (Adipose-Derived Mesenchymal Stem Cells), covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Angiographic Delivery of AD-MSC for Ulcerative Colitis [Phase 1]